SEC Tracker
Get the app
KRMD · XBRL financial data

KORU Medical Systems financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (KRMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue7,0037,186*8,1988,4308,1808,839*9,63510,19510,40210,895*11,76512,045
Cost of goods and services sold2,6612,855*3,0952,9502,9943,276*3,5893,7194,1384,078*4,5334,199
Gross profit4,3424,331*5,1035,4805,1865,563*6,0466,4766,2656,817*7,2317,846
Research and development1,2931,288*1,4761,1341,5341,114*1,1151,1959331,145*1,3171,069
Selling, general and administrative4,6245,013*5,3585,3205,1285,827*5,9595,3845,9956,041*6,5825,940
Total operating expenses6,1336,529*7,0656,6726,8897,152*7,2916,7887,1327,365*8,0967,219
Operating income (loss)(1,791)(2,198)*(1,961)(1,192)(1,703)(1,590)*(1,245)(313)(868)(547)*(865)627
Other income (expense)135169*3721411380*737937*——
Income tax expense (benefit)(300)5,445*———year only—17(0)5*—6
Net income (loss)(1,368)(7,466)*(1,936)(989)(1,581)(1,561)*(1,166)(207)(778)(487)*(807)252
Earnings per share, basic USD per share(0.03)(0.16)*(0.04)(0.02)(0.03)(0.03)*0.030.00——(0.02)0.01
Earnings per share, diluted USD per share(0.03)(0.16)*(0.04)(0.02)(0.03)(0.03)*0.030.000.02—(0.02)0.01
Weighted average shares, basic thousands of shares45,63945,670*45,71245,81145,85145,835*45,98246,194——46,36546,084
Weighted average shares, diluted thousands of shares45,63945,670*45,71245,81145,85145,835*45,98246,19446,23946,330*46,36549,509

Balance sheet

CSV

Fiscal quarters (KRMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents10,77211,48210,82010,4588,8069,5818,7368,0558,4648,8728,7688,288
Accounts receivable4,0514,0454,3935,8465,1655,7215,9494,9295,4126,2105,983—
Inventory4,6773,4813,1472,5893,9282,8043,2793,9484,4123,6784,4764,511
Total current assets21,68720,25619,47919,36618,92919,13218,99917,57919,41919,98920,58819,514
Property and equipment, net3,8203,8383,7563,6794,5524,2914,5344,3714,2364,4714,3363,930
Right-of-use asset3,5453,5143,4293,4153,0642,9662,8682,7682,6682,9562,8572,756
Total assets35,35428,46127,50127,30427,39027,21927,21625,51627,10428,20028,59227,962
Accounts payable9469751,7741,5961,6701,6502,0141,0951,8722,2672,6362,913
Accrued liabilities1,4591,7111,4592,1452,7933,9243,9783,6364,6344,8295,2712,870
Total current liabilities4,2224,4544,8535,1376,3247,2027,7996,0517,8348,1948,8527,180
Lease liability, non-current3,3853,3363,2423,2033,1023,0002,8982,7942,6882,8792,7712,659
Total liabilities7,9248,1078,3838,5999,65710,40510,8718,99010,63911,15211,6699,910
Accumulated deficit(15,846)(23,312)(25,248)(26,237)(27,818)(29,379)(30,545)(30,752)(31,530)(32,017)(32,824)(32,571)
Total stockholders' equity27,43120,35419,11818,70517,73316,81416,34516,52616,46517,04816,92218,052
Total liabilities and equity35,35428,46127,50127,30427,39027,21927,21625,51627,10428,20028,59227,962
Common shares outstanding (cover page) thousands of shares45,66945,71145,76445,85545,83745,95746,14146,23546,32346,37045,93346,172

Cash flows

CSV

Fiscal quarters (KRMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(1,368)(7,466)*(1,936)(989)(1,581)(1,561)*(1,166)(207)(778)(487)*(807)252
Stock-based compensation698*389*700615*610*700*698416*627*973*682458*
Depreciation and amortization216228*231218228211*217209204179*198210
Net cash from operating activities(1,175)*1,097*(347)11*(924)*940*(237)(460)*65*1,095*15216*
Net cash from investing activities(214)*(208)*(133)(149)*(1,102)*51*(447)(29)*(52)*(422)*(90)(577)*
Net cash from financing activities441*(178)*(182)(225)*374*(216)*(161)(192)*396*(265)*(29)(119)*
Net change in cash(947)*710*(662)(362)*(1,652)*775*(845)(681)*409*408*(104)(480)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
KORU Medical Systems8,28812,045216*46.2M— 10-QJun 30, 2026
InfuSystem Holdings96436,9336,777*19.9M— 10-QJun 30, 2026
LENSAR13,56516,495(127)*12.3M106.8 quarters 10-QJun 30, 2026
CVRx64,58615,705(8,826)*26.6M7.3 quarters 10-QJun 30, 2026
TriSalus Life Sciences46,28811,407(10,129)*61.6M4.6 quarters 10-QJun 30, 2026
Neuronetics22,10641,9621,238*77.7M— 10-QSep 30, 2026
Picard Medical382,954(1,352)*2.3M0.0 quarters 10-QJun 30, 2026
Lakeland Industries17,90150,139(404)*9.9M— 10-QJul 31, 2026
Mobia Medical177,09013,505(15,670)*33.3M11.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.